Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02127125 · ClinicalTrials.gov registry record · Phase 2

Mechanism of Microbiome-induced Insulin Resistance in Humans (Aim2)

A Phase 2 study of Insulin Sensitivity, sponsored by The University of Texas Health Science Center at San Antonio.

Completed
Registry status
Phase 2
Development phase
69
Enrollment target
1
Study location

NCT02127125 is a Phase 2 study of Insulin Sensitivity that has completed, run by The University of Texas Health Science Center at San Antonio. The registered enrollment target is 69 participants, roughly in line with the 71-participant average among 29 other Insulin Sensitivity trials with a reported enrollment target. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02127125, a Phase 2 study of Insulin Sensitivity, has completed, sponsored by The University of Texas Health Science Center at San Antonio.

COMPLETED
Registry status
Phase 2
Development phase
69 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to determine whether microbiome modulation and an experimental reduction in plasma LPS concentration improve inflammation and insulin action in insulin resistant (obese and T2DM) subjects.

Conditions Studied

Insulin Sensitivity

Interventions

  • DRUG Maltodextrin
  • DRUG Synbiotic
  • DRUG Sevelamer

Study Locations (1)

Texas

  • Audie L. Murphy VA Hospital, STVHCS - San Antonio

Trial Details

FieldValue
Enrollment Target 69 participants
Start Date 2014-04-10
Est. Completion 2018-09-10
Phase Phase 2

Sponsor

The University of Texas Health Science Center at San Antonio

378 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT02127125

The ClinicalTrials.gov registry entry for NCT02127125 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 69 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 71-participant average among 29 other Insulin Sensitivity trials with a reported enrollment target. The listed sponsor is The University of Texas Health Science Center at San Antonio, which has 378 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Insulin Sensitivity appearing as the primary indexed condition, and to 3 interventions - of which Maltodextrin is the first listed.

NCT02127125 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT02127125 about?

NCT02127125 is a clinical study titled "Mechanism of Microbiome-induced Insulin Resistance in Humans (Aim2)". The purpose of this study is to determine whether microbiome modulation and an experimental reduction in plasma LPS concentration improve inflammation and insulin action in insulin resistant (obese and T2DM) subjects.

What is the current status of trial NCT02127125?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 69 participants. The study started on 2014-04-10. Estimated completion is 2018-09-10.

What conditions does trial NCT02127125 study?

This clinical trial studies the following conditions: Insulin Sensitivity.

What interventions are being tested in trial NCT02127125?

The interventions under investigation include: Maltodextrin (DRUG), Synbiotic (DRUG), Sevelamer (DRUG).

Who is sponsoring clinical trial NCT02127125?

This trial is sponsored by The University of Texas Health Science Center at San Antonio, which has 378 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02127125 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Insulin Sensitivity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Insulin Sensitivity

All registered trials for this condition

Texas

All trials with a study site in Texas

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.